A Diagnostic Map, Long Overdue
A scoping review now appearing in JAMA Psychiatry does something the mental health field has rarely done systematically: it maps which clinical diagnoses appear most often alongside neurodivergence in the research literature, and what that map implies for assessment. The work, indexed on PubMed, is positioned as a structural overview rather than a new clinical trial — but its recommendations land directly inside the assessment room.
For clinicians working in private practice, couples therapy, or grief counseling, the practical question is narrow and immediate: are the diagnostic tools in routine use calibrated to distinguish a primary neurodevelopmental condition from a comorbid mood or anxiety presentation, or are they collapsing the two into a single treatment plan?
What the Review Actually Does
Scoping reviews differ from meta-analyses. They do not pool effect sizes. They survey the territory — what has been studied, how it has been studied, and where the gaps sit. According to the PubMed entry, this particular review maps clinical diagnostic frameworks and neurodiversity paradigms as they appear across mental health research, then issues recommendations for adapting clinical and psychological assessments to improve care for neurodivergent individuals.
That last phrase carries weight. It signals that the authors identified a structural mismatch between standard diagnostic instruments — built around a neurotypical baseline — and the populations they are now asked to evaluate. The modality of assessment, in other words, is itself a variable in the outcome.
Why This Matters in the Therapy Office
Two operational risks follow from the review's framing. First, misattribution: anxiety, depression, or relational distress in a neurodivergent client may be read as primary pathology when it is a downstream effect of a sensory, executive-function, or social-processing load that no standardized screening captured. Second, treatment selection: modalities calibrated to a neurotypical baseline — exposure hierarchies, certain cognitive restructuring protocols, standardized couples communication scripts — can underperform or actively harm a client whose processing profile differs from the assumed norm.
The review's call to adapt assessments is not a call for leniency. It is a call for instrument precision. A baseline that excludes neurodivergent presentation produces efficacy data that does not generalize.
What to Watch
The review's specific recommendations for adapting assessments are not yet visible in the available abstract material. Clinicians tracking this literature should note three markers when the full text becomes accessible: which diagnostic instruments the authors flag as inadequate for neurodivergent populations, whether the recommendations extend to relational and grief presentations specifically, and how the authors reconcile the neurodiversity paradigm — which frames difference rather than deficit — with the categorical structure of the DSM.
Until those details surface, the practical posture is straightforward. Clinicians should expect a shift in assessment protocol over the next several years, and clients seeking therapy should ask prospective providers how their intake process accounts for neurodevelopmental profile before symptoms are assigned to a treatment track.